Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07794800
What this trial is testing

Observational Cohort Study on Ocular Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease in Eye
Ruijin Hospital 340
Testing effectiveness (Phase 2)Study completedNCT00003199
What this trial is testing

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerInflammatory Breast Cancer+5 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT03246906
What this trial is testing

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more
Fred Hutchinson Cancer Center 150
Not applicableWithdrawnNCT04970004
What this trial is testing

Study in Adult and Pediatric Patients With HSCT-TMA

Who this might be right for
Stem Cell Transplant ComplicationsThrombotic Microangiopathies
Alexion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT03774082
What this trial is testing

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

Who this might be right for
Graft vs Host Disease
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)WithdrawnNCT02204020
What this trial is testing

Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Pittsburgh
Large-scale testing (Phase 3)UnknownNCT02241018
What this trial is testing

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

Who this might be right for
Acute Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04572815
What this trial is testing

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Who this might be right for
Hematologic and Lymphocytic DisorderHematopoietic and Lymphoid System Neoplasm
Fred Hutchinson Cancer Center 116
Large-scale testing (Phase 3)Active Not RecruitingNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07829952
What this trial is testing

Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Henan University of Science and Technology 87
Testing effectiveness (Phase 2)Study completedNCT01841333
What this trial is testing

PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionRecurrent Adult Acute Myeloid Leukemia
University of Colorado, Denver 31
Testing effectiveness (Phase 2)Study completedNCT00044733
What this trial is testing

Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer 38
Early research (Phase 1)Ended earlyNCT02846376
What this trial is testing

Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia and Myelodysplastic Syndrome
Hackensack Meridian Health 8
Testing effectiveness (Phase 2)Study completedNCT00521014
What this trial is testing

GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 14
Early research (Phase 1)Ended earlyNCT00087009
What this trial is testing

Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT07094464
What this trial is testing

Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation

Who this might be right for
TP53-mutated MDS and AMLAllogeneic Hematopoietic Stem Cell Transplantation
Daihong Liu 20
Testing effectiveness (Phase 2)Ended earlyNCT05370976
What this trial is testing

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.

Who this might be right for
Cytomegalovirus Infections
University Hospital, Lille 2
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT01754389
What this trial is testing

Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 138
Testing effectiveness (Phase 2)Study completedNCT03270748
What this trial is testing

Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
Gruppo Italiano Trapianto di Midollo Osseo 78
Next Page